Search research articles
Contact Us
Filters
Showing results (191-200 of 278) with videos related to
Page
of 28
Sort By:
Breast (Edinburgh, Scotland)
|
October 16, 2020
Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study
Peter A Fasching, J Thaddeus Beck, Arlene Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2011
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial
Wolfgang Eiermann, Tadeusz Pienkowski, John Crown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2024
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
Dennis J Slamon, Véronique Diéras, Hope S Rugo, et al.
The Oncologist
|
July 12, 2020
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain
Miguel Martin, Angel Guerrero-Zotano, Ángel Montero, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 19, 2022
Effects of capecitabine as part of neo-/adjuvant chemotherapy - A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients
Marion T van Mackelenbergh, Fenja Seither, Volker Möbus, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 28, 2021
Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice
Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Maria Del Monte-Millán, et al.
Revista De Psiquiatria Y Salud Mental
|
June 14, 2016
Cardiovascular and metabolic monitoring of children and adolescents on antipsychotic treatment: A cross-sectional descriptive study
Miquel de la Torre Villalobos, Luis Miguel Martin-López, María Isabel Fernández Sanmartín, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 2, 2016
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy
Kathrin Strasser-Weippl, Nora Horick, Ian E Smith, et al.
Pediatric Diabetes
|
May 28, 2011
Changes in cardiometabolic risk factors, appetite-controlling hormones and cytokines after a treatment program in overweight adolescents: preliminary findings from the EVASYON study
Javier Romeo, David Martinez-Gomez, L Esperanza Diaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2010
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer
Adel Tabchy, Vicente Valero, Tatiana Vidaurre, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 278) with videos related to
Sort By:
Page
of 28
Breast (Edinburgh, Scotland)
|
October 16, 2020
Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study
Peter A Fasching, J Thaddeus Beck, Arlene Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2011
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial
Wolfgang Eiermann, Tadeusz Pienkowski, John Crown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2024
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
Dennis J Slamon, Véronique Diéras, Hope S Rugo, et al.
The Oncologist
|
July 12, 2020
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain
Miguel Martin, Angel Guerrero-Zotano, Ángel Montero, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 19, 2022
Effects of capecitabine as part of neo-/adjuvant chemotherapy - A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients
Marion T van Mackelenbergh, Fenja Seither, Volker Möbus, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 28, 2021
Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice
Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Maria Del Monte-Millán, et al.
Revista De Psiquiatria Y Salud Mental
|
June 14, 2016
Cardiovascular and metabolic monitoring of children and adolescents on antipsychotic treatment: A cross-sectional descriptive study
Miquel de la Torre Villalobos, Luis Miguel Martin-López, María Isabel Fernández Sanmartín, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 2, 2016
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy
Kathrin Strasser-Weippl, Nora Horick, Ian E Smith, et al.
Pediatric Diabetes
|
May 28, 2011
Changes in cardiometabolic risk factors, appetite-controlling hormones and cytokines after a treatment program in overweight adolescents: preliminary findings from the EVASYON study
Javier Romeo, David Martinez-Gomez, L Esperanza Diaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2010
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer
Adel Tabchy, Vicente Valero, Tatiana Vidaurre, et al.
Page
of 28